drug

risedronate sodium

Marketedupdated 2mo ago

by Allergan Finance LLC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Jan 9, 2028

~1.5 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (3)

Jan 9, 2028formulationUS 76454591.5y
Jan 9, 2028formulationUS 76454601.5y
Jan 16, 2026formulationUS 8246989

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 4

Trials studying risedronate sodium

phase4Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Womencompletedn=149